These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1770156

  • 21. Clonazepam: sleep laboratory study of efficacy and withdrawal.
    Kales A, Manfredi RL, Vgontzas AN, Baldassano CF, Kostakos K, Kales JD.
    J Clin Psychopharmacol; 1991 Jun; 11(3):189-93. PubMed ID: 2066457
    [Abstract] [Full Text] [Related]

  • 22. A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly.
    Mamelak M, Csima A, Buck L, Price V.
    J Clin Psychopharmacol; 1989 Aug; 9(4):260-7. PubMed ID: 2671059
    [Abstract] [Full Text] [Related]

  • 23. Dose-related effects of estazolam on sleep of patients with insomnia.
    Roehrs T, Zorick F, Lord N, Koshorek GL, Roth T.
    J Clin Psychopharmacol; 1983 Jun; 3(3):152-6. PubMed ID: 6135720
    [Abstract] [Full Text] [Related]

  • 24. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B, Anderer P, Brandstätter N, Frey R, Grünberger J, Klösch G, Mandl M, Wetter T, Zeitlhofer J.
    Neuropsychobiology; 1994 Jun; 29(2):69-90. PubMed ID: 8170529
    [Abstract] [Full Text] [Related]

  • 25. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P, Nir T, Laudon M, Zisapel N.
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [Abstract] [Full Text] [Related]

  • 26. Multi-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia.
    Fabre LF, Brachfeld J, Meyer LR, Slowe IA, Calvo R, Metzler C.
    J Clin Psychiatry; 1978 Aug; 39(8):679-82. PubMed ID: 28313
    [Abstract] [Full Text] [Related]

  • 27. Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats.
    Hirase M, Ishida T, Kamei C.
    Eur J Pharmacol; 2008 Nov 12; 597(1-3):46-50. PubMed ID: 18789918
    [Abstract] [Full Text] [Related]

  • 28. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun 12; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 29. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M, Mizuki Y, Yamamoto K, Uchida S, Watanabe Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):839-47. PubMed ID: 17328999
    [Abstract] [Full Text] [Related]

  • 30. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Rüther E, Wiegand MH, Laakmann G, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M.
    Pharmacopsychiatry; 2002 Sep 09; 35(5):165-74. PubMed ID: 12237787
    [Abstract] [Full Text] [Related]

  • 31. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M, Attali P, Coquelin JP.
    Clin Ther; 1993 Sep 09; 15(1):127-36. PubMed ID: 8458042
    [Abstract] [Full Text] [Related]

  • 32. Minimal rebound insomnia after treatment with 10-mg zolpidem.
    Ware JC, Walsh JK, Scharf MB, Roehrs T, Roth T, Vogel GW.
    Clin Neuropharmacol; 1997 Apr 09; 20(2):116-25. PubMed ID: 9099463
    [Abstract] [Full Text] [Related]

  • 33. Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena.
    Bianchi M, Musch B.
    Int Clin Psychopharmacol; 1990 Apr 09; 5 Suppl 2():139-45. PubMed ID: 2387981
    [No Abstract] [Full Text] [Related]

  • 34. Effects of zopiclone as compared to flurazepam on sleep in women over 40 years of age.
    Quadens OP, Hoffman G, Buytaert G.
    Int Pharmacopsychiatry; 1982 Apr 09; 17 Suppl 2():146-55. PubMed ID: 7188372
    [Abstract] [Full Text] [Related]

  • 35. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R, Rüther E, Farr I, Emilien G, Salinas E.
    J Clin Psychiatry; 1999 Aug 09; 60(8):536-44. PubMed ID: 10485636
    [Abstract] [Full Text] [Related]

  • 36. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May 09; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 37. Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
    Mauri MC, Gianetti S, Pugnetti L, Altamura AC.
    Int J Clin Pharmacol Res; 1993 May 09; 13(3):173-7. PubMed ID: 7901174
    [Abstract] [Full Text] [Related]

  • 38. Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis.
    Walsh JK, Muehlbach MJ, Lauter SA, Hilliker NA, Schweitzer PK.
    J Rheumatol; 1996 Feb 09; 23(2):245-52. PubMed ID: 8882027
    [Abstract] [Full Text] [Related]

  • 39. Profile of mood states changes during and after 5 weeks of nightly triazolam administration.
    Bliwise DL, Seidel WF, Cohen SA, Bliwise NG, Dement WC.
    J Clin Psychiatry; 1988 Sep 09; 49(9):349-55. PubMed ID: 3047100
    [Abstract] [Full Text] [Related]

  • 40. The effects of a single night's dosing with triazolam on sleep the following night.
    Mamelak M, Csima A, Price V.
    J Clin Pharmacol; 1990 Jun 09; 30(6):549-55. PubMed ID: 2355105
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.